Logo
Friday, 03 July 2020
Logo
The News and Media Division of The Insight Partners
Tuesday, 23 Jun 2020 07:00 pm

E.coli Testing Market Grow Significantly, Product Types, Segmentation, Major Factors, Top Regions, Key Players – Forecast 2027

The E. coli testing market is expected to reach US$ 2,527.73 million by 2027 from US$ 1,506.95 million in 2019; it is estimated to grow at a CAGR of 6.8% from 2020 to 2027.

By SMN Bureau
newsImage
 

E. coli testing is conducted to determine the biotoxicity in healthcare-related applications such as medical, food, life sciences, and environmental sciences. E. coli are gram negative opportunistic bacteria that can cause food- and water-borne infectious diseases and food poisoning. It is also responsible for water contamination that may lead to chronic gastrointestinal diseases. The bacteria have several molecular advantages, which makes it a model organism of choice in various biotechnological researches. The E. coli testing market growth is attributed to factors such as increasing E. coli testing, growing product innovations, and rising research activities. On the other hand, testing challenges is the major factor limit the market growth.

Request sample PDF copy at: https://www.theinsightpartners.com/sample/TIPRE00007152/

A few of the prominent players operating in the E. coli testing market are Bio-Rad Laboratories, Inc; Pro-Lab Diagnostics, Inc.; Abbott (Alere Inc.); IDEXX Laboratories, Inc.; Meridian Bioscience, Inc.; BD; Thermo Fisher Scientific, Inc.; CPI International; Biomerieux Inc.; and Hologic, Inc.  The market players are focused on acquisitions of other industry players to sustain their position in the market. For instance, in March, 2019, Meridian acquired GenePOC's molecular diagnostics business portfolio, with a main objective to leverage the rapid, high-quality diagnostics testing solutions of GenePOC as well as to guide and support the diagnosis for facilitating targeted therapeutic decisions for infectious diseases.

The E. coli testing market, by technology, is segmented monoclonal antibodies, differential light scattering, molecular diagnostics, immunoassays, chromatography, flow cytometry, gel microdroplets, and diagnostic imaging. The monoclonal antibodies segment held the largest share of the market in 2019. Monoclonal antibodies are widely used to detect the strains of E. coli in water and clinical samples, and they can identify a single epitope within an antigen, which is an advantage over the polyclonal antibodies. Thus, it is expected to retain its dominance during the forecast period. However, the immunoassays segment is estimated to register the highest CAGR in the market during the forecast period.

The growth of the market is attributed to the factors such as increasing E. coli testing needs, growing product innovations, and rising research activities. On the other hand, testing challenges is the major factor is likely to restraint the market growth during the forecast period.

End User Insights

Based on end user, the E. coli testing market is segmented into commercial or private labs, physician offices, hospitals, public health labs, and academic research institutes. The public health labs segment held the largest share of the market in 2019. However, the academic research institutes segment is estimated to register the highest CAGR in the market during the forecast period.

Strategic Insights

Merger and acquisitions are the more commonly adopted strategies by companies in the E. coli testing market, which enables them expand their global footprints, and product and service portfolios. The market players adopt the product launches strategy to enlarge their global customer base, which also permits them to maintain their brand name globally.

The report segments the global E. coli testing market as follows:

Global E. coli Testing Market – By Technology

  • Monoclonal Antibodies
  • Differential Light Scattering
  • Molecular Diagnostics
  • Immunoassays
  • Chromatography
  • Flow Cytometry
  • Gel Microdroplets
  • Diagnostic Imaging

Global E. coli Testing Market – By End User

  • Commercial or Private Labs
  • Physician Offices
  • Hospitals
  • Public Health Labs
  • Academic Research Institutes

Purchase Copy of This Report at:  https://www.theinsightpartners.com/buy/TIPRE00007152/

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.  

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

Tags E.coli Testing Market

SMN Bureau

Smart Market News brings you the stories of adopting innovative solutions and strategies that have been changing the world. Our insights on products, solutions, companies, and adoption of best practices help in understanding the markets better and make smarter decisions.


Smarter Decisions with Smart News

Smart Market News is committed to getting its readers the latest updates and insights on industries that help in making “smarter” business decisions. With insights and inputs from corporate decision makers, we bring you the stories of adopting innovative solutions and strategies that have been changing the world. Our editorial insights on products, solutions, companies, and adoption of best practices not only help in understanding the markets better, but also prove to be a complete package for your information needs.

media@smartmarketnews.com | sales@smartmarketnews.com

Contact Us
Subscribe to our newsletter
Get the latest in your inbox weekly Sign up for the fully charged newsletter
Follow Us:
© The News and Media Division of The Insight Partners 2019 | All Rights Reserved | Privacy Policy